Search - tctmd.com

Displaying 861 - 880 of 1325

Sort: Relevancy | Date

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Conference News TCT 2013

Efficacy of PFO Closure Still Undetermined

October 28, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Industry News

Pie Medical Imaging Solutions Selected by the Cardiovascular Research Foundation’s Angiographic Core Laboratory for Clinical Research and Trials

October 17, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

L.A. McKeown

October 15, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Conference News ESC 2013

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Yael L. Maxwell

September 02, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

Advertisement

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Efficacy of PFO Closure Still Undetermined

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Pie Medical Imaging Solutions Selected by the Cardiovascular Research Foundation’s Angiographic Core Laboratory for Clinical Research and Trials

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content